{"id":"intravitreal-triamcinolone-injections","safety":{"commonSideEffects":[{"rate":"30-50","effect":"Elevated intraocular pressure"},{"rate":"10-20","effect":"Cataract progression"},{"rate":"0.1-1","effect":"Endophthalmitis"},{"rate":"1-5","effect":"Vitreous hemorrhage"},{"rate":"1-3","effect":"Retinal detachment"},{"rate":"5-15","effect":"Floaters"}]},"_chembl":{"chemblId":"CHEMBL1200449","moleculeType":"Small molecule","molecularWeight":"478.51"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Triamcinolone acetonide is a synthetic glucocorticoid that reduces inflammation through multiple pathways including inhibition of phospholipase A2, decreased production of inflammatory cytokines (IL-1, IL-6, TNF-α), and suppression of immune cell infiltration. When injected intravitreally, it achieves high local concentrations in the posterior segment while minimizing systemic exposure, making it effective for treating intraocular inflammatory conditions.","oneSentence":"Triamcinolone is a corticosteroid that suppresses intraocular inflammation by inhibiting inflammatory mediators and immune cell activation in the vitreous.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:16:51.925Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Diabetic macular edema"},{"name":"Retinal vein occlusion with macular edema"},{"name":"Uveitic macular edema"},{"name":"Age-related macular degeneration with choroidal neovascularization"}]},"trialDetails":[{"nctId":"NCT05811351","phase":"PHASE2","title":"A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2023-03-06","conditions":"Geographic Atrophy","enrollment":305},{"nctId":"NCT06882551","phase":"PHASE4","title":"Comparison of Intravitreal Bevacizumab Injection with Combination of Suprachoroidal Triamcinolone Acetonide Along with Intravitreal Bevacizumab Injection in the Treatment of Diabetic Macular Edema in Pseudophakic Patients","status":"COMPLETED","sponsor":"Khyber Teaching Hospital","startDate":"2023-04-01","conditions":"Diabetic Macular Edema (DME)","enrollment":82},{"nctId":"NCT06559488","phase":"NA","title":"IVB for Post-vitrectomy Hemorrhage in Diabetic Eyes","status":"COMPLETED","sponsor":"Universitas Padjadjaran","startDate":"2018-04-02","conditions":"Diabetic Retinopathy, Vitreous Hemorrhage","enrollment":18},{"nctId":"NCT00930189","phase":"PHASE2, PHASE3","title":"Comparative Study With Photodynamic Therapy And Triamcinolone Versus Photodynamic Therapy, Triamcinolone And Ranibizumab In Patients With Subfoveal Choroidal Neovascularization","status":"WITHDRAWN","sponsor":"Asociación para Evitar la Ceguera en México","startDate":"2006-04","conditions":"Subfoveal Choroidal Neovascularization","enrollment":""},{"nctId":"NCT00600301","phase":"PHASE3","title":"Vitrectomy Without Internal Limiting Membrane Removal in the Treatment of Diffuse Diabetic Macular Edema: a Comparative Kenalog Vs Bevacizumab Intravitreal Injection Vs Control Study","status":"WITHDRAWN","sponsor":"Asociación para Evitar la Ceguera en México","startDate":"2008-01","conditions":"Diffuse Diabetic Macular Edema","enrollment":""},{"nctId":"NCT04075136","phase":"PHASE4","title":"Optical Coherence Tomography Angiography (OCTA) - Directed PDT Triple Therapy","status":"WITHDRAWN","sponsor":"Wake Forest University Health Sciences","startDate":"2023-03-30","conditions":"Exudative Age Related Macular Degeneration","enrollment":""},{"nctId":"NCT00229931","phase":"NA","title":"Triamcinolone vs. Laser for Diabetic Macular Edema","status":"COMPLETED","sponsor":"University of Oklahoma","startDate":"2005-11","conditions":"DIABETIC MACULAR EDEMA","enrollment":11},{"nctId":"NCT05413330","phase":"PHASE2, PHASE3","title":"Corticosteroid Injection Combined With Cataract Surgery in Diabetic Eyes.","status":"COMPLETED","sponsor":"Damascus University","startDate":"2020-09-12","conditions":"Diabete Type 2, Cataract, Triamcinolone Acetonide","enrollment":73},{"nctId":"NCT00309192","phase":"PHASE3","title":"Efficacy and Safety Study of Intravitreal Triamcinolone to Treat Diffuse Diabetic Macular Edema","status":"COMPLETED","sponsor":"Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA","startDate":"2006-04","conditions":"Diabetes Mellitus, Macular Edema","enrollment":292},{"nctId":"NCT04812977","phase":"NA","title":"Comparison of Intravitreal Anti-VEGF Versus Combination Therapy in Central Retinal Vein Occlusion","status":"COMPLETED","sponsor":"Hayatabad Medical Complex","startDate":"2018-06-10","conditions":"Central Retinal Vein Occlusion With Macular Edema","enrollment":30},{"nctId":"NCT02556424","phase":"PHASE3","title":"Efficacy and Tolerance Comparison Between Subconjunctival Injection of Triamcinolone and Intravitreal Implant of Dexamethasone for the Treatment of Inflammatory Macular Edema","status":"COMPLETED","sponsor":"Nantes University Hospital","startDate":"2016-01","conditions":"Inflammatory Macular Edema","enrollment":114},{"nctId":"NCT04292756","phase":"NA","title":"Triamcinolone Acetonide in Patients With Serous Pigment Epithelial Detachment","status":"COMPLETED","sponsor":"The Filatov Institute of Eye Diseases and Tissue Therapy","startDate":"2018-03-27","conditions":"Age-Related Macular Degeneration","enrollment":63},{"nctId":"NCT05428683","phase":"NA","title":"Intravitreal Triamcinolone and Moxifloxacin Injection After Cataract Surgery","status":"COMPLETED","sponsor":"Emad Abdel Aal Saliem","startDate":"2020-12-03","conditions":"Pharmacological Action","enrollment":84},{"nctId":"NCT02985619","phase":"PHASE2, PHASE3","title":"Bevacizumabe or Triamcinolone for Persistent Diabetic Macular Edema","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2016-07-21","conditions":"Diabetic Macular Edema","enrollment":100},{"nctId":"NCT02949024","phase":"PHASE1, PHASE2","title":"Suprachoroidal Injection of CLS-TA Alone or With Aflibercept in Subjects With Diabetic Macular Edema","status":"COMPLETED","sponsor":"Clearside Biomedical, Inc.","startDate":"2016-11-10","conditions":"Diabetic Macular Edema","enrollment":20},{"nctId":"NCT03126786","phase":"PHASE2","title":"Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema","status":"COMPLETED","sponsor":"Clearside Biomedical, Inc.","startDate":"2017-07-11","conditions":"Diabetic Macular Edema","enrollment":71},{"nctId":"NCT03203447","phase":"PHASE3","title":"Suprachoroidal Injection of Triamcinolone Acetonide With IVT Anti-VEGF in Subjects With Macular Edema Following RVO","status":"TERMINATED","sponsor":"Clearside Biomedical, Inc.","startDate":"2018-03-05","conditions":"Macular Edema, Retinal Vein Occlusion","enrollment":325},{"nctId":"NCT02980874","phase":"PHASE3","title":"Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO","status":"TERMINATED","sponsor":"Clearside Biomedical, Inc.","startDate":"2017-01-31","conditions":"Macular Edema, Retinal Vein Occlusion","enrollment":460},{"nctId":"NCT01789320","phase":"PHASE1, PHASE2","title":"Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis","status":"COMPLETED","sponsor":"Clearside Biomedical, Inc.","startDate":"2013-02","conditions":"Uveitis, Intermediate Uveitis, Posterior Uveitis","enrollment":11},{"nctId":"NCT02303184","phase":"PHASE2","title":"Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO","status":"COMPLETED","sponsor":"Clearside Biomedical, Inc.","startDate":"2015-01","conditions":"Macular Edema, Retinal Vein Occlusion","enrollment":46},{"nctId":"NCT02255032","phase":"PHASE2","title":"Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis","status":"COMPLETED","sponsor":"Clearside Biomedical, Inc.","startDate":"2014-10","conditions":"Uveitis, Macular Edema, Uveitis, Posterior","enrollment":22},{"nctId":"NCT04460001","phase":"PHASE2, PHASE3","title":"Injection of Ranibizumab Versus Combination of Ranibizumab and Triamcinolone Acetate for (CRVO)","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2019-05-16","conditions":"Ophthalmopathy","enrollment":100},{"nctId":"NCT04153253","phase":"PHASE4","title":"Intravitreal Aflibercept Injection or Early Vitrectomy for Diabetic Vitreous Hemorrhage","status":"COMPLETED","sponsor":"Al Hadi Hospital","startDate":"2018-03-07","conditions":"Diabetic Vitreous Hemorrhage","enrollment":34},{"nctId":"NCT00444600","phase":"PHASE3","title":"Laser-Ranibizumab-Triamcinolone for Diabetic Macular Edema","status":"COMPLETED","sponsor":"Jaeb Center for Health Research","startDate":"2007-03","conditions":"Diabetic Retinopathy, Diabetic Macular Edema","enrollment":691},{"nctId":"NCT02441907","phase":"PHASE4","title":"Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Diabetic Macular Edema","status":"COMPLETED","sponsor":"Unity Health Toronto","startDate":"2015-08","conditions":"Diabetic Macular Edema","enrollment":16},{"nctId":"NCT02221453","phase":"PHASE2","title":"Cytokine Levels in Patients With Persistent Diabetic Macular Edema Treated With Triamcinolone Acetonide","status":"COMPLETED","sponsor":"Unity Health Toronto","startDate":"2015-09","conditions":"Diabetic Macular Edema","enrollment":3},{"nctId":"NCT04069780","phase":"NA","title":"Suprachoroidal Injection of Triamcinolone Acetonide for Management of Diabetic Macular Edema","status":"UNKNOWN","sponsor":"Azza Mohamed Ahmed Said","startDate":"2019-03-13","conditions":"Safety, Efficacy","enrollment":45},{"nctId":"NCT02598869","phase":"PHASE4","title":"Posterior Subtenon Versus Intravitreal Injection of Triamcinolone Acetonide for Treatment of Uveitic Cystoid Macular Edema","status":"WITHDRAWN","sponsor":"Oregon Health and Science University","startDate":"2015-11-30","conditions":"Uveitis, Cystoid Macular Edema","enrollment":""},{"nctId":"NCT02374060","phase":"PHASE3","title":"PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial","status":"COMPLETED","sponsor":"JHSPH Center for Clinical Trials","startDate":"2015-06-16","conditions":"Macular Edema, Uveitis","enrollment":192},{"nctId":"NCT02806752","phase":"PHASE4","title":"Intravitreal Ranibizumab and TA Combination Therapy vs. Ranibizumab Monotherapy in Polypoidal Choroidal Vasculopathy","status":"UNKNOWN","sponsor":"Aier School of Ophthalmology, Central South University","startDate":"2017-01","conditions":"Wet Macular Degeneration","enrollment":120},{"nctId":"NCT02447185","phase":"PHASE3","title":"25-G Vitrectomy With Ranibizumab or Triamcinolone Acetonide on PDR in China-Randomized Clinical Trial","status":"UNKNOWN","sponsor":"JUNYAN ZHANG","startDate":"2015-06","conditions":"Proliferative Diabetic Retinopathy","enrollment":200},{"nctId":"NCT02294656","phase":"PHASE1","title":"Acute Pseudophakic Cystoid Macular Edema Treatment Trial: Intravitreal Ranibizumab Versus Triamcinolone Acetonide","status":"COMPLETED","sponsor":"Soll Eye","startDate":"2014-11","conditions":"CYSTOID MACULAR EDEMA","enrollment":4},{"nctId":"NCT00105027","phase":"PHASE3","title":"The Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study","status":"COMPLETED","sponsor":"The Emmes Company, LLC","startDate":"2004-10","conditions":"Macular Edema, Cystoid, Retinal Vein Occlusion","enrollment":682},{"nctId":"NCT01243086","phase":"PHASE2","title":"OZURDEX in Age Related Macular Degeneration as Adjunct to Ranibizumab","status":"COMPLETED","sponsor":"McMaster University","startDate":"2011-03","conditions":"Wet Macular Degeneration","enrollment":10},{"nctId":"NCT00780780","phase":"PHASE3","title":"Efficacy Study of Triamcinolone Associated With Nepafenac for Treatment of Diabetic Macular Edema","status":"COMPLETED","sponsor":"Federal University of São Paulo","startDate":"2007-07","conditions":"Diabetic Macular Edema","enrollment":40},{"nctId":"NCT01267422","phase":"NA","title":"Safety and Efficacy Study of rAAV2-ND4 Treatment of Leber Hereditary Optic Neuropathy (LHON)","status":"COMPLETED","sponsor":"Bin Li","startDate":"2011-04","conditions":"Leber Hereditary Optic Neuropathy","enrollment":9},{"nctId":"NCT02457026","phase":"NA","title":"Adjunctive Photodynamic Therapy + Aflibercept vs. Afilbercept Alone for PDA in NV AMD","status":"WITHDRAWN","sponsor":"Duke University","startDate":"2016-01","conditions":"Neovascular Age-related Macular Degeneration","enrollment":""},{"nctId":"NCT00100009","phase":"PHASE3","title":"Triamcinolone Acetonide Plus Laser Therapy to Treat Age-Related Macular Degeneration","status":"COMPLETED","sponsor":"National Eye Institute (NEI)","startDate":"2004-12-09","conditions":"Macular Degeneration","enrollment":30},{"nctId":"NCT00071227","phase":"PHASE1","title":"Eye Injections of Triamcinolone Acetonide for Retinal Blood Vessel Disorders","status":"COMPLETED","sponsor":"National Eye Institute (NEI)","startDate":"2003-10-15","conditions":"Macular Degeneration, Retinal Vein Occlusion","enrollment":16},{"nctId":"NCT00105404","phase":"PHASE3","title":"Treatment of Diabetic Macular Edema: Triamcinolone Injections Vs. Laser Photocoagulation","status":"COMPLETED","sponsor":"National Eye Institute (NEI)","startDate":"2005-03-09","conditions":"Diabetic Retinopathy, Diabetic Macular Edema, DME","enrollment":5},{"nctId":"NCT00101764","phase":"PHASE1","title":"Intravitreal v. Sub-tenon Injections of Triamcinolone Acetonide for Macular Edema in Retinal Disorders","status":"COMPLETED","sponsor":"National Eye Institute (NEI)","startDate":"2005-01-05","conditions":"Macular Degeneration, Retinal Vein Occlusion, Diabetic Retinopathy","enrollment":120},{"nctId":"NCT01774474","phase":"PHASE3","title":"PRevention of Macular EDema After Cataract Surgery","status":"COMPLETED","sponsor":"Maastricht University Medical Center","startDate":"2013-07-10","conditions":"Cystoid Macular Edema, Cataract, Diabetes Mellitus","enrollment":1127},{"nctId":"NCT02379000","phase":"PHASE4","title":"TTT Versus TTT and Triamcinolone to Decrease Exudation in Choroidal Melanoma After Proton Beam Therapy","status":"UNKNOWN","sponsor":"Charite University, Berlin, Germany","startDate":"2015-01","conditions":"Exudative Retinal Detachment, Uveal Melanoma","enrollment":50},{"nctId":"NCT00561236","phase":"","title":"Does Intravitreal Injection of Triamcinolone Acetonide Impairs the Adrenal Function","status":"COMPLETED","sponsor":"HaEmek Medical Center, Israel","startDate":"2007-04","conditions":"Secondary Adrenal Insufficiency","enrollment":28},{"nctId":"NCT00367133","phase":"PHASE3","title":"Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema","status":"COMPLETED","sponsor":"Jaeb Center for Health Research","startDate":"2004-07","conditions":"Diabetic Macular Edema","enrollment":840},{"nctId":"NCT00445003","phase":"PHASE3","title":"Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy","status":"COMPLETED","sponsor":"Jaeb Center for Health Research","startDate":"2007-03","conditions":"Proliferative Diabetic Retinopathy, Diabetic Macular Edema","enrollment":333},{"nctId":"NCT02328118","phase":"PHASE2, PHASE3","title":"25-Gauge Vitrectomy With Ranibizumab or Triamcinolone Acetonide on Proliferative Diabetic Retinopathy in China","status":"UNKNOWN","sponsor":"JUNYAN ZHANG","startDate":"2015-02","conditions":"Proliferative Diabetic Retinopathy","enrollment":120},{"nctId":"NCT00737971","phase":"PHASE4","title":"Efficacy Study of Triamcinolone and Bevacizumab Intravitreal for Treatment of Diabetic Macular Edema","status":"COMPLETED","sponsor":"Rubens Belfort Jr.","startDate":"2008-08","conditions":"Diabetic Macular Edema","enrollment":142},{"nctId":"NCT00682539","phase":"PHASE4","title":"Intraocular Anti-VEGF Compared With Intraocular Triamcinolone in Patients With Diabetic Macular Edema","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2007-10","conditions":"Diabetic Macular Edema","enrollment":71},{"nctId":"NCT00242580","phase":"PHASE3","title":"A Safety and Efficacy Study Comparing the Combination Treatments of Verteporfin Therapy Plus One of Two Different Doses of Intravitreal Triamcinolone Acetonide and the Verteporfin Therapy Plus Intravitreal Pegaptanib","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2005-09","conditions":"Macular Degeneration, Choroidal Neovascularization","enrollment":111},{"nctId":"NCT01504074","phase":"","title":"Morphological and Functional Evaluation of Irvine-Gass Syndrome","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2011-11","conditions":"Irvine Gass Syndrome","enrollment":50},{"nctId":"NCT01746875","phase":"NA","title":"A Study Testing if Medicine Can Make Pigment Epithelium Detachments Regress and Stabilize the Vision in Eyes","status":"TERMINATED","sponsor":"Norwegian University of Science and Technology","startDate":"2014-02","conditions":"Macular Degeneration, Retinal Detachment","enrollment":9},{"nctId":"NCT00764244","phase":"PHASE3","title":"Laser Versus Vitrectomy Versus Intravitreal Triamcinolone Injection for Diabetic Macular Edema","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2005-01","conditions":"Diabetic Macular Edema, Diabetes","enrollment":72},{"nctId":"NCT00815360","phase":"PHASE2","title":"Ranibizumab and Peripheral Scatter Laser in Patients With Diabetic Macular Edema and Peripheral Nonperfusion","status":"COMPLETED","sponsor":"Retina Associates of Florida, P.A.","startDate":"2008-02","conditions":"Diabetic Macular Edema","enrollment":22},{"nctId":"NCT00846625","phase":"PHASE2","title":"Study of Uveitic Macular Edema Treated With Ranibizumab or Steroids","status":"WITHDRAWN","sponsor":"University of Utah","startDate":"2009-11","conditions":"Macular Edema, Uveitis","enrollment":""},{"nctId":"NCT02310295","phase":"NA","title":"Prospective, Randomized Clinical Trial Comparing Macular Photocoagulation With or Without Intravitreal Bevacizumab or Triamcinolone for the Treatment of Diabetic Macular Edema","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2009-01","conditions":"Diabetic Macular Edema","enrollment":45},{"nctId":"NCT01175395","phase":"PHASE1, PHASE2","title":"20089 TA+Lucentis Combo Intravitreal Injections for Treatment of Neovascular Age-related Macular Degeneration (AMD)","status":"COMPLETED","sponsor":"University of Illinois at Chicago","startDate":"2010-09","conditions":"Age-Related Macular Degeneration, Choroidal Neovascularization","enrollment":10},{"nctId":"NCT01614509","phase":"NA","title":"Combined Therapy of Posterior Subtenon Triamcinolone Acetonide and Intravitreal Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion","status":"COMPLETED","sponsor":"Yeungnam University College of Medicine","startDate":"2012-01","conditions":"Branch Retinal Vein Occlusion","enrollment":45},{"nctId":"NCT00315640","phase":"PHASE2","title":"Anecortave Acetate for Treatment of Steroid Induced Intraocular Pressure (IOP) Elevation","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2005-12","conditions":"Eye Diseases","enrollment":70},{"nctId":"NCT00211419","phase":"PHASE1","title":"Study of the Combination of Anecortave Acetate and Triamcinolone Acetonide for the Treatment of Exudative Age-Related Macular Degeneration (AMD)","status":"COMPLETED","sponsor":"Manhattan Eye, Ear & Throat Hospital","startDate":"","conditions":"Maculopathy, Age-Related","enrollment":""},{"nctId":"NCT01404364","phase":"NA","title":"Use of Intravitreal Triamcinolone and Retrobulbar Chlorpromazine as Alternatives to the Management of Painful Blind Eye","status":"COMPLETED","sponsor":"Hospital Governador Celso Ramos","startDate":"2010-01","conditions":"Blind Painful Eye, Refractory Glaucoma, Control of Pain Through Drug Injection","enrollment":36},{"nctId":"NCT01342159","phase":"NA","title":"Intravitreal Bevacizumab and Triamcinolone in Diabetic Macular Edema","status":"COMPLETED","sponsor":"Hallym University Medical Center","startDate":"2009-03","conditions":"Diabetic Macular Edema","enrollment":80},{"nctId":"NCT01249937","phase":"PHASE2","title":"Sub-tenon Triamcinolone Acetonide in Age-Related Macular Degeneration as Adjunct to Ranibizumab","status":"UNKNOWN","sponsor":"University Health Network, Toronto","startDate":"2011-01","conditions":"Wet Macular Degeneration","enrollment":30},{"nctId":"NCT01178697","phase":"PHASE2","title":"Intravitreal Bevasizumab Versus Intravitreal Triamcinolone in Central Retinal Vein Occlusion (CRVO)","status":"UNKNOWN","sponsor":"Shahid Beheshti University of Medical Sciences","startDate":"2010-01","conditions":"Central Retinal Vein Occlusion","enrollment":""},{"nctId":"NCT00148330","phase":"PHASE2, PHASE3","title":"Open Label Extension of a Clinical Trial of Intravitreal Triamcinolone for Diabetic Macular Oedema-TDMX Study","status":"COMPLETED","sponsor":"University of Sydney","startDate":"2005-05","conditions":"Diabetic Macular Oedema","enrollment":64},{"nctId":"NCT00148265","phase":"PHASE2, PHASE3","title":"A Multicentre Randomised Clinical Trial of Laser Treatment Plus Intravitreal Triamcinolone for Diabetic Macular Oedema","status":"COMPLETED","sponsor":"University of Sydney","startDate":"2005-04","conditions":"Diabetic Macular Oedema","enrollment":54},{"nctId":"NCT00447031","phase":"NA","title":"Combination Therapy for Neovascular Age Related Macular Degeneration","status":"WITHDRAWN","sponsor":"Yonsei University","startDate":"2007-03","conditions":"Macular Degeneration","enrollment":""},{"nctId":"NCT01053858","phase":"NA","title":"Triamcinolone or Bevacizumab for Central Retinal Vein Occlusion With Poor Vision","status":"COMPLETED","sponsor":"Hallym University Medical Center","startDate":"2008-01","conditions":"Central Retinal Vein Occlusion With 20/200 or Worse Visual Acuity","enrollment":38},{"nctId":"NCT01044329","phase":"PHASE2","title":"Intravitreal Bevasizumab Versus Intravitreal Triamcinolone in Branch Retinal Vein Occlusion","status":"UNKNOWN","sponsor":"Shahid Beheshti University of Medical Sciences","startDate":"2010-01","conditions":"Branch Retinal Vein Occlusion","enrollment":90},{"nctId":"NCT00532142","phase":"PHASE2, PHASE3","title":"The ROVO Study: Radial Optic Neurotomy for CVO","status":"COMPLETED","sponsor":"Rudolf Foundation Clinic","startDate":"2005-04","conditions":"Central Retinal Vein Occlusion","enrollment":""},{"nctId":"NCT00801450","phase":"PHASE1, PHASE2","title":"Intravitreal Injection Versus Sub-Tenon's Infusion of Triamcinolone Acetonide for Refractory Diabetic Macular Edema During Cataract Surgery","status":"UNKNOWN","sponsor":"University of Sao Paulo","startDate":"2007-09","conditions":"Diabetic Macular Edema","enrollment":24},{"nctId":"NCT00744666","phase":"PHASE4","title":"IntraVitreal Triamcinolone Acetonide: Preventing Raised Eye-pressure by Tracking Elevations After Topical Steroids","status":"UNKNOWN","sponsor":"Hotel Dieu Hospital","startDate":"2008-09","conditions":"Vitreoretinal Disease, Ocular Hypertension","enrollment":70},{"nctId":"NCT00874744","phase":"PHASE2","title":"Comparison of Single Intravitreal Injection of Triamcinolone or Bevacizumab for the Treatment of Diabetic Macular Edema","status":"COMPLETED","sponsor":"Universidade Federal de Goias","startDate":"2008-03","conditions":"Diabetic Macular Edema","enrollment":13},{"nctId":"NCT00849537","phase":"PHASE1, PHASE2","title":"The Effect of Intravitral Injection of Triamcinolone Combined With Cataract Surgery (Phacoemulsification) on Diabetic Macular Edema and Diabetic Retinopathy","status":"UNKNOWN","sponsor":"Shahid Beheshti University of Medical Sciences","startDate":"2008-04","conditions":"Diabetic Retinopathy","enrollment":""},{"nctId":"NCT00371111","phase":"PHASE1","title":"To Compare Therapeutic Effect of Intravitreal Bevacizumab and Triamcinolone in Resistant Uveitic Cystoid Macular Edema","status":"UNKNOWN","sponsor":"Shahid Beheshti University of Medical Sciences","startDate":"2006-08","conditions":"Resistant Cystoid Macular Edema","enrollment":40},{"nctId":"NCT00370370","phase":"PHASE3","title":"Intravitreal Bevacizumab vs. Bevacizumab Combined With Triamcinolone for Neovascular AMD","status":"UNKNOWN","sponsor":"Shahid Beheshti University of Medical Sciences","startDate":"2005-11","conditions":"Neovascular Age-Related Macular Degeneration","enrollment":""},{"nctId":"NCT00407849","phase":"PHASE1, PHASE2","title":"Intravitreal Triamcinolone Acetonide for Treatment of Refractory Diffuse Diabetic Macular Edema","status":"UNKNOWN","sponsor":"Federal University of São Paulo","startDate":"2006-10","conditions":"Diabetic Retinopathy","enrollment":50},{"nctId":"NCT00668239","phase":"NA","title":"Diffuse Diabetic Maculopathy With Intravitreal Triamcinolone or Laser","status":"COMPLETED","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2004-09","conditions":"Macular Edema","enrollment":14},{"nctId":"NCT00612261","phase":"NA","title":"Sheathotomy vs. Intravitreal Triamcinolone for Branch Retinal Vein Occlusion","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2006-10","conditions":"Macular Edema, Branch Retinal Vein Occlusion","enrollment":40},{"nctId":"NCT00140803","phase":"PHASE2","title":"Study Of Combined VISUDYNE Therapy With Kenalog In CNV Secondary To Age-Related Macular Degeneration","status":"COMPLETED","sponsor":"Manhattan Eye, Ear & Throat Hospital","startDate":"2003-10","conditions":"Age-Related Macular Degeneration","enrollment":106},{"nctId":"NCT00491712","phase":"NA","title":"Comparison of Efficacy Between Silicone Ahmed Glaucoma Valves With and Without Intravitreal Triamcinolone Injection","status":"UNKNOWN","sponsor":"Federal University of São Paulo","startDate":"2005-09","conditions":"Neovascular Glaucoma","enrollment":49},{"nctId":"NCT00300014","phase":"NA","title":"Efficacy and Safety of Intravitreal Triamcinolone Acetonide in Eyes With Post Vitrectomy Diabetic Vitreous Hemorrhage","status":"UNKNOWN","sponsor":"Asan Medical Center","startDate":"2006-01","conditions":"Post Vitrectomy State, Recurrent Diabetic Vitreous Hemorrhage","enrollment":30},{"nctId":"NCT00476918","phase":"PHASE1","title":"Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema","status":"UNKNOWN","sponsor":"Heidelberg University","startDate":"2006-07","conditions":"Diabetic Retinopathy, Diabetic Macular Edema","enrollment":60},{"nctId":"NCT00468351","phase":"PHASE1","title":"Intravitreal Triamcinolone Acetonide Versus Intravitreal Bevacizumab for Refractory Diabetic Macular Edema (IBEME Study)","status":"UNKNOWN","sponsor":"University of Sao Paulo","startDate":"2006-04","conditions":"Diabetic Macular Edema","enrollment":""},{"nctId":"NCT00443521","phase":"PHASE2, PHASE3","title":"Triamcinolone as Adjunctive Treatment to Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2005-03","conditions":"Diabetic Retinopathy","enrollment":30},{"nctId":"NCT00391144","phase":"PHASE2, PHASE3","title":"Avastin for CNV Secondary to Pattern Dystrophy","status":"UNKNOWN","sponsor":"University of Trieste","startDate":"2006-07","conditions":"Choroidal Neovascularization Secondary to Pattern Dystrophy","enrollment":5},{"nctId":"NCT00167518","phase":"PHASE2, PHASE3","title":"Intravitreal Triamcinolone for Clinically Significant Diabetic Macular Oedema That Persists After Laser Treatment (TDMO)","status":"COMPLETED","sponsor":"University of Sydney","startDate":"2002-03","conditions":"Diabetic Macular Oedema","enrollment":70}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":30,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["- KENACORT RETARD","- Triamcinolone Acetonid"],"phase":"phase_3","status":"active","brandName":"Intravitreal triamcinolone injections","genericName":"Intravitreal triamcinolone injections","companyName":"Assistance Publique - Hôpitaux de Paris","companyId":"assistance-publique-h-pitaux-de-paris","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Triamcinolone is a corticosteroid that suppresses intraocular inflammation by inhibiting inflammatory mediators and immune cell activation in the vitreous. Used for Diabetic macular edema, Retinal vein occlusion with macular edema, Uveitic macular edema.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}